Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

ACELYRIN Plans To Determine The Best Path Forward For Development Of Izokibep Based On Outcome Of Its Ongoing Evaluation And Planned Audit

Author: Benzinga Newsdesk | November 27, 2023 05:37pm

This will include a determination of whether to transition its ongoing trials to a new CRO or complete the trials with the current Contract Research Organization (CRO).

Posted In: SLRN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist